Funding for this research was provided by:
Japan Agency for Medical Research and Development (15bk0104027h0003, 16bk0104016h0004, 17bk0104016h0005, JP15bm0609003, JP16bm0609003, JP17bm0804003, JP18bm0804003, JP19bm0804003, JP20bm0804003, JP21bm0804003)
Japan Society for the Promotion of Science (JP21J12528)
Received: 31 December 2021
Accepted: 22 February 2022
First Online: 1 July 2022
: No applicable.
: Human ethics approval was obtained from the Ethics Committee of Keio University School of Medicine (Approval Number: 20080016).
: The Program for Initiative Research Projects from Keio University to H.O. F.O. is employed by K Pharma, Inc., and H.O. received research funding from K Pharma, Inc. The other authors declare that they have no competing interests.